Literature DB >> 20624961

Neurofibromin regulates corticostriatal inhibitory networks during working memory performance.

Carrie Shilyansky1, Katherine H Karlsgodt, Damian M Cummings, Kyriaki Sidiropoulou, Molly Hardt, Alex S James, Dan Ehninger, Carrie E Bearden, Panayiota Poirazi, J David Jentsch, Tyrone D Cannon, Michael S Levine, Alcino J Silva.   

Abstract

Neurofibromatosis type I (NF1) is one of the most common single-gene causes of learning disabilities. Here, we use behavioral working memory probes and electrophysiological studies in a mouse model of NF1 (Nf1 heterozygous null mutants; Nf1(+/-)) to demonstrate that (i) Neurofibromin regulates prefrontal and striatal inhibitory networks, specifically activity-dependent GABA release and (ii) is required for working memory performance, with inhibition-dependent working memory deficits seen in Nf1(+/-) mice. We find that increased inhibition in medial prefrontal cortex (mPFC) is sufficient to alter persistent activity in a biophysical model of an mPFC microcircuit, suggesting a possible mechanism for Nf1(+/-) working memory deficits. Accordingly, working memory assays applied during functional MRI (fMRI) studies in human subjects with NF1 reveal hypoactivation of corticostriatal networks, which is associated with impaired working memory performance. Collectively, these integrative mouse and human studies reveal molecular and cellular mechanisms contributing to working memory deficits in NF1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624961      PMCID: PMC2919968          DOI: 10.1073/pnas.1004829107

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  52 in total

1.  Thalamic-cortical-striatal circuitry subserves working memory during delayed responding on a radial arm maze.

Authors:  S B Floresco; D N Braaksma; A G Phillips
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

Review 2.  Do rats have a prefrontal cortex?

Authors:  Harry B M Uylings; Henk J Groenewegen; Bryan Kolb
Journal:  Behav Brain Res       Date:  2003-11-30       Impact factor: 3.332

3.  Dopaminergic modulation of visual attention and working memory in the rodent prefrontal cortex.

Authors:  Yogita Chudasama; Trevor W Robbins
Journal:  Neuropsychopharmacology       Date:  2004-09       Impact factor: 7.853

Review 4.  Advances in functional and structural MR image analysis and implementation as FSL.

Authors:  Stephen M Smith; Mark Jenkinson; Mark W Woolrich; Christian F Beckmann; Timothy E J Behrens; Heidi Johansen-Berg; Peter R Bannister; Marilena De Luca; Ivana Drobnjak; David E Flitney; Rami K Niazy; James Saunders; John Vickers; Yongyue Zhang; Nicola De Stefano; J Michael Brady; Paul M Matthews
Journal:  Neuroimage       Date:  2004       Impact factor: 6.556

Review 5.  Divergent plasticity of prefrontal cortex networks.

Authors:  Bita Moghaddam; Houman Homayoun
Journal:  Neuropsychopharmacology       Date:  2007-10-03       Impact factor: 7.853

6.  Mnemonic coding of visual space in the monkey's dorsolateral prefrontal cortex.

Authors:  S Funahashi; C J Bruce; P S Goldman-Rakic
Journal:  J Neurophysiol       Date:  1989-02       Impact factor: 2.714

7.  Neuron activity related to short-term memory.

Authors:  J M Fuster; G E Alexander
Journal:  Science       Date:  1971-08-13       Impact factor: 47.728

8.  Impaired delayed spatial win-shift behaviour on the eight arm radial maze following excitotoxic lesions of the medial prefrontal cortex in the rat.

Authors:  Claire L Taylor; Mary P Latimer; Philip Winn
Journal:  Behav Brain Res       Date:  2003-12-17       Impact factor: 3.332

Review 9.  Frontal syndrome and disorders of executive functions.

Authors:  Olivier Godefroy
Journal:  J Neurol       Date:  2003-01       Impact factor: 4.849

10.  Optic nerve glioma in mice requires astrocyte Nf1 gene inactivation and Nf1 brain heterozygosity.

Authors:  M Livia Bajenaru; M Rosario Hernandez; Arie Perry; Yuan Zhu; Luis F Parada; Joel R Garbow; David H Gutmann
Journal:  Cancer Res       Date:  2003-12-15       Impact factor: 12.701

View more
  69 in total

Review 1.  The contribution of GABAergic dysfunction to neurodevelopmental disorders.

Authors:  Kartik Ramamoorthi; Yingxi Lin
Journal:  Trends Mol Med       Date:  2011-04-21       Impact factor: 11.951

Review 2.  Genetic architecture of declarative memory: implications for complex illnesses.

Authors:  Carrie E Bearden; Katherine H Karlsgodt; Peter Bachman; Theo G M van Erp; Anderson M Winkler; David C Glahn
Journal:  Neuroscientist       Date:  2011-08-10       Impact factor: 7.519

Review 3.  An update on the central nervous system manifestations of neurofibromatosis type 1.

Authors:  J Stephen Nix; Jaishri Blakeley; Fausto J Rodriguez
Journal:  Acta Neuropathol       Date:  2019-04-08       Impact factor: 17.088

4.  Disruption of Critical Period Plasticity in a Mouse Model of Neurofibromatosis Type 1.

Authors:  Mariska van Lier; M Hadi Saiepour; Koen Kole; Juliette E Cheyne; Nawal Zabouri; Thomas Blok; Yi Qin; Emma Ruimschotel; J Alexander Heimel; Christian Lohmann; Christiaan N Levelt
Journal:  J Neurosci       Date:  2020-06-11       Impact factor: 6.167

5.  GIT1 is associated with ADHD in humans and ADHD-like behaviors in mice.

Authors:  Hyejung Won; Won Mah; Eunjin Kim; Jae-Won Kim; Eun-Kyoung Hahm; Myoung-Hwan Kim; Sukhee Cho; Jeongjin Kim; Hyeran Jang; Soo-Churl Cho; Boong-Nyun Kim; Min-Sup Shin; Jinsoo Seo; Jaeseung Jeong; Se-Young Choi; Daesoo Kim; Changwon Kang; Eunjoon Kim
Journal:  Nat Med       Date:  2011-04-17       Impact factor: 53.440

6.  Risky Decision Making in Neurofibromatosis Type 1: An Exploratory Study.

Authors:  Rachel K Jonas; EunJi Roh; Caroline A Montojo; Laura A Pacheco; Tena Rosser; Alcino J Silva; Carrie E Bearden
Journal:  Biol Psychiatry Cogn Neurosci Neuroimaging       Date:  2017-03

7.  Nf1 regulates alcohol dependence-associated excessive drinking and gamma-aminobutyric acid release in the central amygdala in mice and is associated with alcohol dependence in humans.

Authors:  Vez Repunte-Canonigo; Melissa Herman; Tomoya Kawamura; Henry R Kranzler; Richard Sherva; Joel Gelernter; Lindsay A Farrer; Marisa Roberto; Pietro Paolo Sanna
Journal:  Biol Psychiatry       Date:  2014-08-19       Impact factor: 13.382

8.  HCN channels are a novel therapeutic target for cognitive dysfunction in Neurofibromatosis type 1.

Authors:  A Omrani; T van der Vaart; E Mientjes; G M van Woerden; M R Hojjati; K W Li; D H Gutmann; C N Levelt; A B Smit; A J Silva; S A Kushner; Y Elgersma
Journal:  Mol Psychiatry       Date:  2015-04-28       Impact factor: 15.992

Review 9.  Impaired synaptic plasticity in RASopathies: a mini-review.

Authors:  Florian Mainberger; Susanne Langer; Volker Mall; Nikolai H Jung
Journal:  J Neural Transm (Vienna)       Date:  2016-08-26       Impact factor: 3.575

Review 10.  The molecular basis of cognitive deficits in pervasive developmental disorders.

Authors:  Aditi Bhattacharya; Eric Klann
Journal:  Learn Mem       Date:  2012-08-16       Impact factor: 2.460

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.